Bio-Works Technologies AB (publ) - Current Ratio

The Current Ratio as of October 2026 (TTM) for Bio-Works Technologies AB (publ) (BIOWKS.ST) is 6.88

According to Bio-Works Technologies AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 6.88. This represents a change of 63.94% compared to the average of 4.19 of the last 4 quarters.

Bio-Works Technologies AB (publ) (BIOWKS.ST) Historical Current Ratio (quarterly & annually)

How has BIOWKS.ST Current Ratio performed in the past?

The mean historical Current Ratio of Bio-Works Technologies AB (publ) over the last ten years is 7.76. The current 6.88 Current Ratio has changed 8.76% with respect to the historical average. Over the past ten years (40 quarters), BIOWKS.ST's Current Ratio was at its highest in in the June 2018 quarter at 17.87. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Bio-Works Technologies AB (publ) (BIOWKS.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Bio-Works Technologies AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bio-Works Technologies AB (publ) (BIOWKS.ST) Average Current Ratio

How has BIOWKS.ST Current Ratio performed in the past?

The current Current Ratio of Bio-Works Technologies AB (publ) (BIOWKS.ST) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Bio-Works Technologies AB (publ) (BIOWKS.ST) Current Ratio vs. Peers

How is BIOWKS.ST’s Current Ratio compared to its peers?

Bio-Works Technologies AB (publ)’s Current Ratio is less than Initiator Pharma A/S (7.69), greater than IRLAB Therapeutics AB (publ) (1.55), greater than Lipum AB (publ) (0.58), less than Karolinska Development AB (publ) (14.37), greater than Isofol Medical AB (publ) (5.17), greater than Annexin Pharmaceuticals AB (1.19), greater than Alzinova AB (publ) (2.11), greater than iZafe Group AB (1.05), greater than SenzaGen AB (2.90), greater than Clinical Laserthermia Systems AB (publ) (0.94),

Build a custom stock screener for Bio-Works Technologies AB (publ) (BIOWKS.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Works Technologies AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bio-Works Technologies AB (publ) (BIOWKS.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bio-Works Technologies AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.